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 Abstract 
 
This study investigated the variability in self-reported sexual behavior data collected 
using different methods. The motivation for the study was to better understand sexual 
behaviour as a means of reducing HIV incidence among women. Respondents for the 
study were women enrolled in the Microbicides Development Programme pilot study at 
the Africa Centre for Health and Population Studies in the Umkhanyakude district of 
KwaZulu Natal, South Africa. These 51 women were asked to use a placebo vaginal gel 
before sex for 4 weeks.  Three methods of sexual behaviour data collection were used in 
order to evaluate the accuracy of data collected.  A coital diary was kept for all 4 weeks, a 
sexual behaviour questionnaire was administered at the end of 4 weeks and then an in-
depth interview was conducted within the following week. Variations in reporting were 
subsequently probed regarding reporting of the number of sex acts, condom usage, and 
gel usage. There was a variance in individual reports – using different data collection 
tools – of  numbers of sexual acts, condom use, and gel use. The majority of 
discrepancies were reported by the women to be due to misunderstandings or recall bias.  
 
The study concludes that using multiple methods of sexual behaviour data collection 
methods adds value in terms of being able to report on the level of variance thereby 
improving the confidence with which the data can be interpreted. Further analysis of the 
in-depth interviews is necessary to assess the level of social desirability bias. Variability 
does exist among data collection methods, but case record forms could be used as a 
substitute for in depth interviews in large scale microbicides clinical trials since this 
variability is not major. 
 
 
 
 
 
 
  
Opsomming 
 
Hierdie studie het die afwyking in self-aangemelde seksuele gedrag deur verskillende 
metodes bestudeer. Die motivering vir die studie was om seksuele gedrag beter te 
verstaan en die kennis aan te wend as ‘n metode om MIV infeksie by vroue te verminder. 
Respondente vir die studie was ingeskrewe vroue in die ‘Microbicides Development 
Programme’ loods navorsingsprojek by die ‘Africa Centre for Health and Population 
Studies’ in die Umkhanyakude distrik van KwaZulu-Natal, Suid-Afrika. Hierdie 51 vroue 
is gevra om vir 4 weke ŉ placebo jel te gebruik voordat hulle seksueel verkeer. Drie 
metodes is gebruik om data te versamel oor seksuele gedrag om die akkuraatheid van die 
data te evalueer. Respondente is gevra om dagboek van hul seksuele aktiwiteite vir die 4 
weke te hou, om ŉ seksuele gedrag vraelys aan die einde van die 4 weke voltooi,  en 'n 
diepte onderhoud binne die volgende week te voer. Afwykings in verslaggewing is verder 
bespreek met betrekking tot die aantal seksuele dade, gebruik van kondome en gebruik 
van jel. Daar was afwyking in individuele rapportering – deur verskeie data insamelings 
gereedskap te gebruik – van aantal seksuele dade, kondoom gebruik, en die gebruik van 
jel. Die meerderheid van hierdie afwykings wat gerapporteer is, was as gevolg van 
misverstande en onewewigtige herroepping.   
 
Die gevolgtrekking van hierdie studie is dat die gebruik van veelvuldige metodes om 
inligting oor seksuele gedrag te versamel die waarde verhoog in terme van die vermoë 
om te rapporteer oor die vlak van afwyking en daardeur verhoog dit die akkuraatheid 
waarmee die inligting verklaar kan word.  Verdere analise van die in-diepte onderhoude 
is nodig om die vlak van sosiale aanvaarbaarheid te bepaal.   
 
Daar bestaan veranderlikheid tussen die verskillende data insamelingsmetodes, maar ‘n 
siekteverslag  kan in-diepte onderhoude in grootskaalse kliniese eksperimente vervang, 
aangesien die veranderlikheid nie groot is nie. 
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CHAPTER 1 
 
1.1 Background to Study 
 
When used properly and consistently, condoms are the most effective method of 
protection against HIV and STI’s. However, despite considerable efforts by numerous 
agencies and an overall increase in condom sales over the past decade, only a small 
proportion of the sexually active population in many countries use condoms, and those 
who do may do so irregularly and only with selected partners (Mayaud & Mabey, 2004). 
Lack of condom use in sub-Saharan Africa contributes to the high prevalence of HIV in 
this region (WHO, 2000). Lurie et. al. (2002), found that condom use was very low in 
rural South Africa; fewer than 20% of men reported that they ever used a condom.  
 
Many women are not able to negotiate condom use with their sexual partners, and are at 
increased risk of HIV infection. To address this problem, the Microbicides Development 
Programme (MDP) aims to develop and implement an acceptable alternative prevention 
method to decrease the spread of HIV. To this end, the MDP has commissioned a multi-
site randomized double-blind clinical trial to evaluate the efficacy of the PRO 2000 
microbicide gel in reducing the risk of vaginally acquired HIV infection.  Prior to this 
clinical trial, a pilot study to evaluate the acceptability of gel use during sexual 
intercourse and trial procedures using a placebo gel (HPTN 035) was conducted in all six 
sites of the MDP: Uganda; Tanzania; Zambia; Johannesburg, South Africa; Durban, 
South Africa; and Africa Centre for Health and Population Studies in Mtubatuba, KZN,  
South Africa. 
 
Because the majority of vaginally acquired HIV infections are due to heterosexual 
intercourse (MDP 301 Pilot Protocol), there is a growing emphasis on understanding 
sexual behaviour as a means to reducing HIV incidence among women. The most 
common methods of collecting sexual behavior data include questionnaires/surveys, 
coital diaries, and in-depth interviews, all of which rely on self-reporting (Devon et al, 
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2005; Minnis et al, 2001; Hays et al, 2001; Ramjee et al, 1999; Kurth et al, 2004). 
Computer-assisted interviews have also been used to obtain sexual behaviour data, but 
are not a viable method of data collection in many populations (Kurth et al, 2004) due to 
limited technological resources and low levels of computer literacy. 
 
Despite increasing use of sexual behavior data collection methods, limited research has 
been conducted regarding the accuracy and reliability of self-reporting for each 
independent method and across different methods. Some studies indicate that the 
reliability of self-reported sexual behavior data is questionable (Lagarde 1995).  Accurate 
measures of sexual behaviour are crucial for informing interventions aimed at mitigating 
the impact of HIV/AIDS, and so a key challenge for all sexual behavior-related research 
is to generate unbiased and precise measures of individual and population sexual 
behaviour patterns. Methods are needed to minimize measurement error that may be 
introduced by participation bias, recall bias, social desirability and participant’s 
willingness to report sensitive sexual behaviour (Fenton, 2000). 
 
Prior research suggests that self-reported sexual behavior will vary depending on the 
method used to collect the data (Obermeyer, 2005). Pool et al (1995) cited by Obermeyer 
(2005) have shown that convergence between survey data and in-depth interviews are 
uneven, with interviews sometimes validating survey results and sometimes contradicting 
them. Ramjee, Leigh and Webb found that there is a significant level of agreement 
between data collected through questionnaires and coital diaries. However, for questions 
that required numerical responses (i.e. number of partners, number of condoms used), 
higher mean numbers were reported in coital diaries in all cases except for oral sex with 
partners, in which there was no significant difference between questionnaire responses 
and coital diary responses.  
 
Previous studies suggest that the in-depth interview provides the most accurate reflection 
of the participant’s true experiences (Obermeyer, 2005). However, it is difficult to draw 
global conclusions about bias in methods from small numbers of studies, especially if the 
  3
sample populations were quite different. For this reason, it is important to evaluate 
discrepancies within the same population, and to increase the number of studies available 
for comparison.  
 
The Africa Centre pilot study provides an excellent opportunity to explore variability 
between methods of sexual behavior data collection within the same population. 
Triangulation of data regarding gel use and sexual practices can be conducted using data 
from questionnaires, coital diaries, and in-depth interviews. During in-depth interviews, 
participants are asked to explain reasons for discrepancies between self-reported sexual 
behavior among these three data collection methods. The following is a secondary 
analysis of the secondary objective of the Microbicide Pilot study, whose protocol was 
approved by the University of KZN ethics committee.  
 
Established in 1997, the Africa Centre for Health and Population Studies is a joint project 
of the University of KwaZulu-Natal and the Medical Research Council of South Africa. 
The Centre conducts research on population and health issues of importance to 
developing countries; develops local research capacity; and identifies ways to overcome 
the health challenges facing sub-Saharan Africa. Based near Mtubatuba in rural Kwa-
Zulu Natal and with a virology laboratory in the Nelson R. Mandela Medical School in 
Durban, the Centre has a staff of 400 and an annual budget of $4,200,000. The main 
focus of Africa Centre research is quantitative data. This is supported by qualitative 
ethnographic surveillance. Research covers three integrated areas: 
- Population Studies: the Africa Centre Demographic Information System (ACDIS) 
collects demographic, socio-economic and health data from 11,000 households in 
a 435 square kilometre area of the Hlabisa District in KwaZulu-Natal. The total 
population surveyed is 90,000. The Demographic Surveillance System (DSS) is 
the most comprehensive in Africa. Data collection began in February 2000, with 
homesteads visited every six months to register new individuals and households, 
update demographic variables, and record all births, deaths and migrations. Since 
2001, the DSS has also collected socio-economic data, and since 2003 the Centre 
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has offered every adult in the demographic surveillance area the opportunity to be 
tested for important health problems including HIV. HIV testing is enabling 
researchers to discover how many people are living with the virus as well as 
finding ways in which HIV-negative people can avoid infection and HIV-positive 
people can remain healthy for longer.  
- Child Health: studies focus on critical health issues among mothers and children, 
including comparing the effect on child health of breastfeeding or formula-
feeding in a context of high HIV infection rates; testing the effectiveness of 
Nevirapine in preventing mother-to-child HIV transmission; and identifying ways 
of improving child health through the provision of inexpensive micronutrient 
supplements.  
- HIV Prevention and Treatment: the Africa Centre’s Durban-based virology 
laboratory is genotyping strains of HIV and sexually transmitted diseases (STDs) 
and studying vaccines and microbicides for HIV prevention. In 2004, the Centre 
will begin offering anti-retroviral treatment to approximately 600 people living 
with AIDS in the Demographic Surveillance Area.  
Longitudinal studies such as the ACDIS benefit from being able to track changes over 
time and build up a robust picture of communities. Longitudinal data provide the most 
comprehensive answers to questions regarding, for example, the role of temporary 
migration in community life, the impact and cost-effectiveness of health interventions, 
links between economic well-being and health status, and the effect of government policy 
on the wealth of rural households. Demographic trends, too, can be more closely 
monitored by longitudinal studies.  
Research on HIV/AIDS demonstrates the benefits of the Demographic Surveillance 
System. The DSS allows researchers to measure the burden of disease in the surveillance 
area; highlight new trends in HIV infection; describe patterns and determinants of health 
service utilisation and their impact on demographic and health outcomes; assess the 
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ongoing effect of different intervention strategies on the spread of the epidemic; and, 
potentially, monitor resistance levels to anti-retroviral drugs.  
As well as measuring core variables such as household structure, migrations and key 
events, the DSS also allows for the inclusion of add-on modules. These include sections 
on household socio-economic status and women’s reproductive health. Like the core 
data, these are collected over time and over the entire eligible population. Short-term 
modules, moreover, have answered questions regarding child grants and cholera. 
Separate studies, such as those related to Child Health and HIV Prevention and 
Treatment, also involve the DSS population but may be initiated by investigators outside 
the population studies research group.  
The Africa Centre aims to make the ACDIS data as widely available as possible while 
balancing the interests of data subjects, data controllers and data users. Access to ACDIS 
analytical datasets is provided on the basis of analysis plans submitted by prospective 
data users to the ACDIS Principal Investigator. Investigators will be able to obtain the 
data they wish to work with from a website, subject to access control.  
1.2 Research objectives and hypotheses 
 
The Microbicide Pilot study conducted at the Africa Centre site in Mtubatuba, South 
Africa sought to assess gel acceptability and optimize the trial procedures developed for 
the proposed phase III randomized double-blind placebo-controlled trial. The Pilot study 
was designed to ensure that key procedures and methods were to be correctly 
implemented and be effective.  One of the study aims was to assess the validity and 
reliability of sexual behavior data from a questionnaire compared to the more detailed 
methods of the coital diary and in-depth interview. Sexual behaviour data obtained 
through case record forms, coital diaries and in-depth interviews was analyzed to 
evaluate the extent to which data reported using the different methods varies.  
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For the purposes of this study, I evaluated discrepancies among data collected from IDI’s 
vs. coital diaries and questionnaires. I also assumed that the use of three different 
methods may influence the reporting in each.  The research questions were therefore: 
1) Is there variability in sexual behaviour data collected using multiple techniques?   
2) What are the reasons for this variability (qualitative)? 
In this study, the Null hypothesis was that there is no variability of sexual behavior data 
collected by different methods. The alternative hypothesis was that sexual behavior data 
varies according to type of data collection method. 
 
The scientific hypotheses to be assessed were as follows: 
• There is variability of sexual behavior data collected through different methods 
• Variability differs according to time frame of sexual behavior being queried (sex 
in the last week vs. sex in the last 4 weeks) 
• Variability of reported condom use across methods will differ from variability of 
reported gel use across methods  
 
1.3 Operational definition of concepts 
1.3.1 Case record forms (CRF) 
Case record forms are structured sexual behaviour questionnaires administered by the 
HIV counselors. The CRF’s were completed at the final visit to the clinic.  If a participant 
reported having sex in the previous week, detailed information of sexual behavior in the 
previous week was collected.  On the other hand, if a participant reported no sexual acts 
during the previous week, detailed information concerning sex acts from the previous 
four weeks was collected. 
 
1.3.2 Coital Diaries (CD) 
Coital Diaries are written text and pictorial sexual behaviour questionnaires, which are 
participant self-administered with each sex act. Participants were issued these, along with 
the gel, at the enrollment visit, and asked to complete the CD and bring them back after 
two weeks for review. The coital diaries provided another tool to trace product use over 
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the course of the month and quantify it in conjunction with other practices such as 
condom use and the use of vaginal inserts. 
1.3.3 In-depth interviews (IDI) 
In-depth interviews were conducted with all participants who completed the CRF and the 
CD. The interviews were twofold, with the first part focusing on independent data 
collection and the second part probing about reasons for inconsistencies in the IDI vs. 
CRF and CD.  At the end of the IDI, triangulation of data obtained using all three 
different methods of data collection was conducted.  The data used depended on whether 
a participant had reported sex acts in the week prior to the final visit to the clinic.  If a 
participant stated that she had no sex acts during that time period, the sexual behavior 
data pertained to sex acts occurring in the four weeks prior to the final clinical visit. 
1.3.4 Variability (outcome measure) 
For the purposes of this study, variability was defined as the difference in sexual behavior 
data across methods, using the in-depth interview as the gold standard. Variability of data 
from the CRF, coital diary and in-depth interview was assessed for number of sex acts, 
condom use and gel use. Reasons for variability were obtained through the qualitative 
probes about inconsistencies within data collected. 
 
 
 
 
  8
CHAPTER 2 
 
2.1 Sexual Behaviour Data Collection 
2.1.1 Introduction 
In the late 1990s, the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the 
World Health Organization (WHO) introduced second-generation surveillance to 
strengthen and improve national HIV surveillance systems (UNAIDS, 2000). Tailoring 
the surveillance system to the specific needs of the epidemic was done by amongst other 
things supplementing the biological data with behavioral trend data to gain insights into 
the extent to which behavioral changes are responsible for HIV trends (Zaba et al, 2005). 
 
Zaba et al (2005), further stress that the behavioral component of the surveillance system 
should contribute significantly to the ability to predict changes in the HIV incidence rate, 
to assess the potential for the spread of HIV in specific risk population or in the general 
population and to the evaluation of the impact of the programmatic efforts. 
2.1.2 Sexual Behaviour Reporting Biases 
Analysis of the quantity of self-reported sexual behaviour have found evidence of several 
problems including underreporting of ever having had sex among young unmarried 
respondents, underreporting of the number of partners (particularly by women), possible 
exaggeration of the number of partners by some young unmarried men (Curtis & 
Sutherland, 2004). Many behaviors that carry a high risk of HIV infection are also 
socially proscribed, and there is evidence that it is difficult to get individuals to disclose 
such behaviour, especially if it is current or recent (Zaba etal, 2005). Very few studies 
have tried to assess changes in the bias in sexual behaviour reporting overtime, including 
the tendency of the respondents to provide the answer he or she thinks the interviewer 
wants to hear, the social desirability bias. This is a particular source of concern in the 
behavioral surveillance in the context of interventions that promote safer sexual 
behaviors.  
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An important principle in collecting data on sensitive sexual behaviour topics is to use 
standard survey instruments that have been tested in a variety of populations and 
maintained the same quality of implementation. Huygens et al cite a few more areas of 
concern in collecting sexual behaviour data: 
 
• Influence of gender, age and social status of he interviewer  
• Influence of the duration of the interview 
• Risks of misclassification due to translation 
• Research models used 
2.1.3 Sexual Behaviour Collection Methods and Biases 
 
2.1.3.1 Self-administered questionnaires (SAQs) 
Self-administered questionnaires are thought to enhance privacy under appropriate 
conditions. Also one person can administer SAQs to many respondents simultaneously, 
SAQs tend to be very inexpensive to use in a group of respondents too. Catania et al 
(1990), argue that SAQs are limited by respondents’ level of education, reading ability 
and the investigator’s ability to employ terminology understandable to a wider range of 
respondents,  and because there is no opportunity for probing ambiguous responses. 
Catania et al (1990), further stress that respondents may feel less threatened by SAQs 
than by Face-Face-Interviews when answering questions. 
 
SAQs, however, have not always resulted in higher levels of reporting. A study by 
DeLamater and Mac Corquodale (1975) quoted by Catania found that young adult 
women were less likely too report vaginal intercourse on SAQs than in Face-to-Face 
interviews. Although not unequivocal, current evidence suggests that SAQs reduce 
measurement error related to respondents’ privacy concerns, though one might expect 
that language comprehension difficulties would increase measurement error. Therefore 
SAQs provide a useful but limited tool for conducting AIDS-related sex research. 
Biases associated with SAQs are response bias and item-order effects bias. The latter can 
be categorized onto placement effects sand sequencing effects. Catania et al (1990) 
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defines placement effects of the item-order effect as the response bias produced wherein 
the questionnaire item occur relative to the total number of items assessed. For example, 
items occurring in the questionnaire may be unanswered due to respondent’s fatigue. 
Sequencing effects occur when, for instance, the content of earlier items influence the 
later items. 
 
2.1.3.2. Face-Face Interviews (FTFIs) 
FTFIs involve both visual and auditory social contexts, thus one might expect that self- 
presentation bias would be highest on FTFIs, relative to telephonic interviews and SAQs. 
This is the notion that arises from the fact that people wish to present themselves in a 
positive light, thus self-presentation bias may lead to either over-or underreporting of a 
particular sexual behaviour, depending on whether that behaviour has a positive or 
negative social value.  
 
People vary in the degree to which they will bias reports of some or all of their sexual 
activities. Therefore, some people will be generally threatened by questions concerning 
their sexual behaviour and may refuse to answer or may substantially underreport any 
and all activities (giving zero responses). Others may be threatened only by questions 
concerning very specific behaviors that they believe were socially deviant. Bradburn etal 
(1978), found that subjects who rated themselves as very uneasy about sexual questions 
were more likely to refuse to answer vaginal intercourse items. Similarly Catania etal 
(1990), found that the frequency of refusing to answer sexual questions correlated 
significantly with self-reported willingness to disclose sexual information. Although 
these studies support the assumption that presentation bias is a concern in assessing 
sexual behaviour, they do not identify which behaviors are most sensitive to presentation 
bias. 
 
Respondents perceive FTFIs as having greater credibility and may trust the interviewer 
more than in the telephone interviews and SAQs, factors that serve to reduce 
measurement error in sex surveys. Moreover, in FTFIs, interviewers can assist respondent 
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in the use of different response scales and correct their misconceptions about questions. 
Also interviewers may bring into the interview room a calendar to help the respondents 
remember the dates during which they had sex. 
 
2.1.3.3 Diaries 
The diary method has been used as an appropriate method for collecting sequential and 
time-linked data on sexual behaviour since 1982, and has proved to be a realistic tool for 
the study of sexual behaviour in a number of pioneering studies, resistant to interview 
and retrospective bias and yielding detailed and often unique information (Coxon,1999). 
It is undoubtedly a demanding method both for respondents and researchers, subject to 
selection bias and it is unlikely to be a substitute for survey methods. 
 
Coxon (1999) who studied discrepancies between self-report and recall measures found 
that the sexual diary method is likely to be more accurate than retrospective questionnaire 
data but they are strongly related. In particular: 
 
• Diarist attribute highest certainty in their questionnaire estimates of sexual 
behaviour to the less common sexual acts, and in particular for the higher-risk acts 
which involve anal sex. This is confirmed in the smaller relative discrepancies 
associated with these same acts. 
• At the individual level, post factum questionnaire estimates also yield much the 
same aggregate profile as diary counts, but they consistently yield average 
frequencies. 
• Most individuals have a consistent pattern of over-identical/under-reporting 
estimates across different sexual acts. 
• The main important exception occurs for the highest-risk sexual activity; anal sex 
without a condom which differs markedly according to whether it refers active or 
passive variants. The discrepancies may in part reflect a sort of ‘social 
desirability’ effect. 
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Catania et al (1990), also cite that greater precision of diaries suggest that the 
concordance of estimates from SAQs and coital diaries would be sufficient to validate 
each method, and allow the strengths of each to be capitalized upon. 
 
Although diaries are subject to a number of shortcomings, especially potential selection 
bias and difficulties in use for large populations, the advantages of diaries are also very 
considerable (Catania et al,1990; Coxon, 1999). Most importantly, the short time period 
between the sexual act and its recording makes for greater precision and minimizes 
retrospective error, and diaries also allow more detailed, contextually-specific and 
naturally expressed accounts of behaviour.  
 
2.2 Theoretical Framework Associated with sexual behaviour reporting 
 
Many of the most familiar theories of health behaviour like the theory of reasoned action; 
theory of planned behaviour; health belief model; protection motivation theory and 
subjective expected utility theory can be called continuum theories (Weinstein et al, 
1998). Their approach is to identify variables that influence action (such as perception of 
risk and precaution effectiveness) and to combine them in a prediction equation. It is 
reasonable to assume that behaviour change can be described by a single prediction 
equation but many natural phenomena pass through qualitative different stages. 
 
Stage theory ideas are helpful in reaching the goals of understanding and influencing 
behaviour. The idea that if people at one stage have to address similar issues before they 
can progress to the next stage, the third feature of the stage theory is the requirement that 
people at a stage face similar barriers and, consequently, that they can be helped by 
similar interventions. 
 
Most women in the Microbicides study faced the problem of a partner who does not want 
to use condoms when having sex with them. The accessibility of the nurses and 
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counselors, that offer them condom education; negotiation skills help them realize that 
they can overcome the barriers to the sexual health. 
Weinstein et al (1998), call the seven stage model the Precaution Adoption Process 
Model (PAPM). The stages are: 
 
Stage1: At some initial point, people are unaware of the health issue. 
Stage2: When people first learn something about the issue, they are no longer unaware, 
but they are not necessarily engaged by it either. 
Stage3: People who reach the decision-making stage have become engaged by he issue 
and are considering their response. 
Stage4: This decision-making process can result in one of two outcomes. If the decision 
is made not to the action, the precaution adoption process ends, at least for the time 
being. 
Stage5: But once the people have decided to adopt the precaution; 
Stage6: The next step is to initiate the behaviour. 
Stage7: The last stage, if relevant, indicates that the behaviour has been maintained over 
time.  
 
Reporting sexual behaviour is scary and if the participant does not understand the reasons 
for scientists to ask for sexual behaviour data; the likelihood is that they will decide to 
offer untrue reports or decline to report. With ongoing education about sexuality, condom 
use and safe sex they begin to realize that they are being helped and some may be 
triggered to give truths about their behaviour. This is likely to happen during the In-depth 
interviews which happen during the last visit when the participant knows that she is not 
going to meet the study staff after all. Thus for this study the IDI has been used as the 
gold standard. 
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CHAPTER 3 
MATERIALS AND METHODS 
 
3.1 Introduction 
 
The Africa Centre Microbicides Pilot Study was conducted from July to October 2005 in 
the Umkhanyakude district in rural KwaZulu-Natal. This section describes the materials 
and methods used to collect and analyse data from the Microbicides Pilot Study. 
 
3.1.1 Study Area and Population 
The Africa Centre pilot study enrolled 51 female participants from primary health care 
facilities at three clinics: KwaMsane; Mtubatuba and Madwaleni. These are government 
clinics in rural KwaZulu Natal at the Umkhanyakude district, in the Mtubatuba area, and 
primarily provide family planning and immunization services. Women were recruited 
from these clinics through talks about microbicides by HIV/AIDS counselors at the 
clinic’s waiting room. Interested women were invited to receive further information about 
the study on a one-on-one basis. Flip charts and information sheets were used to explain 
details and procedures for the study. This information session formed part of the 
informed consent procedure. After giving informed consent, the participant was taken 
through the screening process which included completion of some case record forms, 
blood test and general examinations. 
 
3.2 Sampling design and enrolment criteria 
 
The study population consisted of women aged 18 years and above who were sexually 
active and visited Africa Centre clinic sites in Kwa-Zulu Natal, South Africa. To join the 
pilot study, women had to be sexually active, willing to undergo HIV testing and receive 
their result, use study gel as instructed, undergo regular speculum examinations and a 
genital infection screen, have regular urine pregnancy tests, receive health education 
about condoms and be able to give informed consent. Women were ineligible if they 
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were unable or unwilling to provide a reliable method of contact for the field team, likely 
to move permanently out of the area within the next year, likely to have sex more than 14 
times a week over the next month, using spermicides regularly, pregnant or within 6 weeks 
postpartum, had grade 3 clinical or laboratory abnormalities, had a known latex allergy, 
participating in any other microbicide study or clinical trial, and/or considered unlikely to 
be able to comply with the study protocol. 
 
The study staff screened 147 women for the microbicides pilot study, of whom 76 were 
eligible and 51 provided consent to enroll in the study. 62 women were excluded from 
participation due to HIV positive status, 6 women were excluded due to pregnancy, and 3 
women were excluded due to sexual inactivity. Fifty participants who completed the 
study were included in the current analysis (systematic convenient sampling design).  
 
3.3 Research Design 
 
The study employed a cross-sectional, non- randomized, open label design (Christensen, 
2004); where female participants were asked to insert 2g (one applicator full) of HPTN 
035 Placebo Gel into their vagina one hour prior to vaginal sexual intercourse for a 
period of 4 weeks. During the screening process, informed consent was obtained after 
providing explanation about the study procedures and forms. Pre-test and post-test 
counseling was provided for all women who consented to be tested for HIV. 
Demographic information forms, sexual behavior forms were filled in for women who 
were eligible and consented to participate.  
 
After screening, participants reported to MDP clinics for 4 follow-up visits: enrollment, 
week 2, week 3, and week 4. Sexual behaviour data was collected using case record 
forms, coital diaries and in-depth interviews. Coital diaries were issued at enrollment, and 
participants were instructed to return completed diaries at the week 2 clinic visit. Fresh 
coital diaries were provided at week 2, and participants returned these completed diaries 
at the week 4 visit, during which time the CRF was also administered. Within two weeks 
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after the final clinic visit, participants were interviewed regarding their sexual behaviour 
and data collection method acceptability. The interview also included probing of 
inconsistencies in sexual behavior reporting. 
 
3.4  Data collection techniques 
3.4.1 Case Record forms 
Demographic data and sexual behaviour data were collected from all 51 enrolled 
participants using the CRF completed by the counselors. The demographic CRF was 
completed at the screening visit, and the sexual behaviour forms were completed at 
enrolment and at the final clinical visit. 
 3.4.2 Coital diaries 
All participants were asked to keep coital diaries whilst they were using the gel. In these 
diaries, participants recorded details of their sexual behaviour, gel and condom use. The 
diaries were completed and reviewed with participants on a weekly basis between 
enrolment and final follow-up visit. 
3.4.3 In-depth interviews 
All participants were interviewed by the social science coordinator or research assistants 
within two weeks of their final clinic follow-up visit. The interviews were semi-
structured, combining an interview guide with spontaneous probes and free discussion. 
At the end of the interviews the diary entries were discussed and any discrepancies with 
the interview examined. All interviews were recorded, transcribed and translated.   
 
3.4.4. Validity and Reliability 
One way of validating the self-reported sexual behaviour data is using the biological 
marker (Catania, Gibson, et al 1990). This is when the validity of self-reported sexual 
behaviour can be corroborated through the biological marker; which is unachievable and 
cumbersome. Since a solid validity index of self-reported sexual behaviour is not 
available; the goal of minimizing measurement error became more important in this 
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study. This included ensuring that participants are asked to report sexual behavior data of 
the same time period across all methods. For this analysis, triangulation was also done to 
achieve some degree of validity and reliability of data.  
3.5 Quality Control and Quality Assurance 
 
Clinic counsellors reviewed coital diaries with participants at the final clinic visit. When 
a participant admitted to have made a mistake; the counsellor used a red pen to correct 
that mistake, and completed documentation of the change. If necessary, the sexual 
behaviour CRF was also corrected by the counsellor.  The clinic manager quality 
controlled both the coital diaries and final visit CRF’s before they were sent to the Africa 
Centre. At the Africa Centre the forms were captured by the Data centre team, and copies 
were filed in the Social Science IDI guide to be used during CD-CRF comparison prior to 
the in-depth interview. 
 
Audio recordings of in-depth interviews were downloaded to the Social Science 
computer, which was password-protected. Transcriptions and translations were done by 
the research assistants and the social science coordinator; quality control of 10% of those 
transcripts was done by the social science coordinator. Coding of transcripts was done 
and quality controlled by the microbicide project leader and the social science 
coordinator. 
3.6 Data management procedures  
 
CRF’s were printed in duplicate and in triplicate. The study staff authorised by the 
Principal investigator entered information directly onto the CRF’s, signed and dated the 
form on completion, and separated the copies. The top copy of the form was sent to the 
data entry team, for capturing into the EpiInfo database. Double entry was done as an 
extra validation control to ensure quality. The bottom copy was kept in a Clinical Folder 
individual to each participant in the clinic. Clinical Folders were stored in the location 
most likely to guarantee security, confidentiality and ability to retrieve individual records.  
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Changes to the bottom copy of the CRF could only be made by the study personnel that 
collected data directly from the participants (counsellors, clinical personnel and 
interviewers), and all changes were signed and dated. Alterations made after separation of 
the two copies were photocopied and sent to the data management team. If the change 
was in response to a query, then the change to the bottom copy of the CRF was made, 
signed and dated and the Query Form completed describing the change. The Query Form 
was also in duplicate and the bottom copy was filed in the Clinical Folder, and the top 
one sent to the data management team. The CD’s were entered into the CD data base. 
 
In order to maintain participant confidentiality, all files, CRF’s and voice text interviews 
were identified using participant study numbers. In-depth interviews were transcribed, 
translated and entered into a separate database to the CRF data for analysis using an 
appropriate qualitative statistical software package. 
 
3.7 Data Analysis 
3.7.1 Statistical packages 
Both quantitative and qualitative data analysis techniques were used in this study. 
Quantitative analysis was conducted using STATA v8. NVivo v2.0 was used for coding 
and analysis of qualitative data. 
3.7.2 Data Analysis 
Analysis of associations between coital diary data, in-depth interview data and data from 
case record forms assisted in identifying relationships between adherence and barriers to 
use with socio-demographic factors.  The in-depth interview (IDI) was used as the gold 
standard for collecting sexual behavior data, and was compared to coital diary and CRF 
data for differences in reporting. 
 
Descriptive statistics were computed for the demographic characteristics of the sample. 
Proportions of gel use and condom use per sex act were calculated using data on number 
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of sex acts, gel and condom use for each woman. These proportions were stratified by 
time frame of sexual behavior reporting (sex in the last week vs. sex in the last 4 weeks). 
Qualitative data analysis was conducted using NVivo.  Reasons for variability in self-
reported sexual behavior across methods were explored and common themes identified 
across subjects. 
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CHAPTER 4 
 
RESEARCH FINDINGS 
 
4.1 Introduction 
 
This section details the results of the above analyses and provides preliminary 
interpretations of these results, which will be further discussed in Chapter 5. 
 
4.2 Results 
4.2.1 Quantitative Results 
Descriptive statistics were calculated for the 51 women enrolled in the microbicides pilot 
study (see Table 1). 
 
Table 1: Descriptive statistics: Summary Statistics for women enrolled (n=51) 
Variable Sub-category N % Mean (SD) Range 
Age  51  31.9 (10.7) 18 - 56 
Relationship status         
 Married  14    
 In relationship 37    
Education level         
 None 2    
 Some primary 14    
 Some secondary 34    
 Some tertiary 1    
Employment status         
 Employed full time 5 9.8   
 Employed part time 5 9.8   
 Student/scholar 4 7.8   
 Work seeker 1 2.0   
 Unemployed 35 68.6   
 Other 1 2.0   
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Source of cash income  41 80.4   
 Own salary/earnings 8 15.7   
 Partner’s salary/earnings 15 29.4   
 Parental contribution 1 2.0   
 Other relative 2 3.9   
 Government grant/child maintenance 23 45.1   
 Child’s father pays some money 4 7.8   
 Other 2 3.9   
Housing      
 Council house 2 3.9   
 Rented house 1 2.0   
 Room inside/outside house 48 94.1   
Religion         
 Christian (unspecified)  8 15.7   
 Christian (catholic) 3 5.9   
 Born again Christian 7 13.7   
 Zionist 24 47.1   
 Shembe 6 11.8   
 Other 3 5.6   
 
Of the 51 enrolled women, 37 (73%) are not legally married and only 14 (27%) are in 
marriage relationships. Most women are literate as 34 (67%) have some secondary 
education. A large number of women are unemployed 35 (68, 6%). 
 
In the analysis, 50 of 51 enrolled women were included (1 woman dropped out prior to 
study completion). The following tables provide information on proportions of condom 
and gel use among study participants. Table 2 provides information on the combined 
sample (n=50), Table 3 describes women who had sex in the last week (n=32), and Table 
4 describes women who had sex in the last 4 weeks (n=18). 
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Table 2: Proportion of condom and gel use per sex acts reported in each of the 3 
data collection methods (n=50). 
 
Method of 
data 
collection 
Total number of 
sex acts reported 
Percentage of acts 
with condoms 
Percentage of acts with 
gel 
CRF 226 45% 85% 
CD 245 45% 82% 
IDI 304 39% 82% 
 
Table 2 shows that across the 3 data collection methods, there is only 6% variability 
in reports of the proportional use of condoms, and 3% variability in reports of the 
proportional use of gel.  
      
      Of the 50 women who completed the study, 82% gave discrepant reports across 1        
of the 3 data collection methods in relation to either number of sex acts, number of 
partners, and type of sex, condom use or gel use. 
 
Table 3: Proportion of condom and gel use per sex acts reported in each of the 3 
data collection methods for women who had sex in the last week (n=32) 
 
Method of data 
collection 
Mean (SD) proportion of 
sex acts with condoms 
Mean (SD) proportion of 
sex acts with gel 
CRF 0.50 (0.49) 0.82 (0.35) 
CD 
 
0.44 (0.48) 0.63 (0.47) 
IDI 0.52 (0.49) 0.84 (0.34) 
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For women who had sex in the last week, there was highest reporting of gel use in the 
IDI and in the CRF, as opposed to low reporting of gel use in the CD. This might 
have been due to the difficulties encountered by women when recording in the CD as 
reported during the IDI.  The reports on sex with a condom are more or less similar 
across all three methods and low.  
 
Table 4: Proportion of condom and gel use per sex acts reported in each of the 3 
data collection methods for women who had sex in the last 4 weeks (n=18). 
Method of data 
collection 
Mean (SD) proportion of 
sex acts with condoms 
Mean (SD) proportion of 
sex acts with gel 
 
CRF 0.26 (0.44) 0.81 (0.33) 
CD 
 
0.28 (0.42) 0.85 (0.25) 
IDI 0.25 (0.42) 0.75 (0.33) 
 
For women who had sex in the last 4 weeks, the reporting of sex acts with gel is 
relatively high across all methods but a bit lower in IDI. It is highest in CD. This is the 
opposite from what was found among women having sex in the last week. This finding 
might be due to recall problems during the IDI, since women were being asked to 
remember their sex acts for the past 4 weeks rather than just 1 week. This suggests that 
the time period being asked about may influence the reporting of sexual behaviour data, 
as well as which data collection instrument will be most accurate. 
 
When comparing groups of those that had sex in the last week and those that had sex in 
the last four weeks, it is found that there is much lower condom use in the last 4 weeks. 
The proportion of gel use is similar in both groups. 
 
 Figure 1: Variability in the reports from 50 women on the number of sex acts, 
condom use and gel use over 1 (62%) or 4 (30%) weeks (8% excluded): 
 
50 reports
4 discrepant 
time periods 
(8%) excluded 
20 reports of  sex acts 
consistent across 2 
methods (40%) 
17 reports of sex acts 
consistent across all 3 
methods (34%) 
9 reports of sex acts 
inconsistent across all 3 
methods (18%) 
4 consistent in 
CRF & CD 
8 consistent 
in CD & IDI 
8 consistent in 
CRF & IDI 
25% (2) 
inconsistent 
on gel use 
13% (1) 
inconsistent on 
gel use, & 13% 
(1) on condom 
use 
18% (3) 
inconsistent on gel, 
& 12% (2) on gel 
and condom use.  
11%  (1) 
1proportionally 
consistent on gel and 
condoms in 3 
methods. 
56% (5) 
proportionally 
consistent on gel & 
condom use in CRF & 
IDI. 1Proportional of times condoms & gel used in 
reported number of sex acts 
 
Of the 51 enrolled women, 33 (65%) had sex in the last week. 18 (54%) of these women 
reported different numbers of sex acts in different data collection methods (see Figure 1). 
Where there was a variance, 72% of women reported a higher number of sex acts in the 
interviews. Of the 18 discrepant reports, we looked at whether the percentage of condom 
and gel use per number of sex acts differed across the 3 methods, and this occurred in 4 
(22%) cases. Out of the 15 cases where the number of sex acts corresponded, 2 (13%) 
reports showed variance in condom use and another 2 (13%) in gel use.  
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Out of 46 reports of number of sex acts that were comparable within a defined time        
frame: 
• 37% (17/46) were consistent across all 3 methods. 
• 72% (33/46) of IDI’s were consistent with at least 1 other method. 
• 63% (29/46) of CRF’s were consistent with at least 1 other method. 
• 63% (29/46) of CDs were consistent with at least 1 other method. 
 
Only 2 women reported more than 1 partner during the study. Both of these reports 
were discrepant across the data collecting methods. One was reported to be an error in 
CD completion (ticked wrong box); the other was only reported in the IDI.  One 
women reported anal sex in the CD and IDI but not the questionnaire. However, due 
to the structure of the CRF and CD, if a woman reported no sex acts in the past week, 
the questions about number of partners and type of sex were omitted by default. 
Therefore, variation across methods in these 2 categories was largely due to blank 
entries in CRF’s and CDs, compared to IDI’s. The under-reporting of anal sex and 
number of partners was reported to be due to social desirability bias (not wanting to 
tell clinic staff). 
 
4.2.2 Qualitative Results:  
4.2.2.1 Reasons for variability as quoted from the In-depth interviews: 
• “I can say it’s because I didn’t tick immediately after having sex and thought I 
had sex because I didn’t tick on time and told myself I had sex on a certain time. I 
then ticked after, I didn’t remember that I did not use it because I was having my 
periods”.  (27 year old women who reported more sex acts & gel use in CD than 
CRF and IDI) 
 
•  “There is somewhere I got mixed up I marked this side and not the other 
side……I used to fill it some other time you see when I went to see this person 
then come back then fill it, I did not bring it with me”.  (A 23 year old who 
reported sex in the last week in IDI, but not in the CD or CRF) 
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• “Maybe I have mixed it up. Maybe it’s me who mixes up it’s only the 9th I 
remember clearly”. 
 
• ”I never used it but I made a mistake by ticking by the time I was counting gels 
used and found that there were 19. It means I had sex and forgot to tick”.  (Women 
who had reported less sex acts on CD). 
 
• “It means the 9th and 10th was supposed to be on this page, I was supposed to open 
here I was confused I saw Saturday then marked it as well as the Sunday.  I used 
to fill it some other time you see when I went to see this person then come back 
then fill it, I did not bring it with me”  
 
4.2.2.2 Other reasons for variability from the triangulation  
• In CD sex reported in the last 4 weeks but in the CRF and IDI sex is reported in 
the last week- the participant gave the reason that the first two weeks worth of CD 
was not taken from her by the study staff so she mistakenly continued to mark the 
sex acts on the 3rd week space instead of the 5th week space. 
• In CRF participant reported gel use with a sex act which in the IDI is reported to 
have been without gel use- the participant gave the reason that she was 
menstruating and is sure that she did not use gel, thus might have forgotten to 
explain during CRF interview. 
• Reported 10 gel use in CRF and CD but 4 in IDI- participant has inserted gels but 
did not continue to have sex for the 6 times thus reported 10 gel use in CRF and 
CD so that the number of sex acts number of used applicators would tally. 
• Inconsistency about gel, condom and no of sex acts- forgotten to tick 2 sex acts, 
where she has used both condom & gel. 
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CHAPTER 5 
 
Conclusions and Recommendations 
 
There was considerable variability in reporting the number of sex acts across the 3 data 
collection methods. The variability in reporting sex acts appears to be predominantly due 
to recall bias, and variability in reporting of condom and gel use appears to be due to 
social desirability bias as confirmed by qualitative interviews. The majority of 
discrepancies were reported by the women to be due to misunderstandings or recall bias 
also obtained from qualitative interviews. 
 
A higher number of sex acts are reported in IDI’s than in other methods, and this is 
probably due to the level of probing involved in IDI’s. However, IDI’s require extensive 
training and time of staff.  In a large scale clinical trial, CRF’s would be the most 
practical way of collecting sexual behaviour data on a regular basis. The results from this 
study suggest that CRF’s are similar to CDs and IDI’s in collecting proportional use of 
condoms and gel per sex acts reported. When assessed against IDI’s, it appears that 
CRF’s may under-estimate the number of at risk sex acts (i.e. sex without a condom). 
However, in the absence of sufficient resources to conduct IDI’s with all participants, the 
use of CRF’s in larger clinical trials should be adequate to collect sexual behaviour data. 
 
There are obvious advantages of using multiple sexual behaviour data collection methods 
in terms of being able to quantify the level of variation across different methods, and 
thereby inform the interpretation of sexual behaviour data. The strength of this analysis is 
that it combined both the quantitative and qualitative models of research which was 
useful in eliciting the reasons for variability. Also the fact that data reported on different 
methods was of the same time frame (either sex reported on last week or on last four 
weeks) was perfect to ensure reliability of data. Strength of this analysis is that there was 
chance to validate the reported sexual behaviour data during the triangulation done within 
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the IDI and the final record of sex acts, gel and condom use in the IDI was the 
triangulated one. The weakness of this analysis is that the sample is small and results 
might not be generalisable to other populations in which studies on sexual behaviour are 
conducted.  
 
Further analysis of the in-depth interviews is necessary to assess the level of social   
desirability bias. Using multiple methods of sexual behaviour data collection methods 
adds value in terms of being able to report on the level of variance thereby improving the 
confidence with which the data can be interpreted. 
 
In summary, this study shows that sexual behaviour data varies according to method of 
data collection, but this variability is minor and would not discourage future studies from 
using CRF’s rather than IDI’s. The results of this study are useful both for the current 
microbicides clinical trial at the Africa Centre site, as well as other microbicides clinical 
trials that rely on accurate and efficient collection of sexual behavior data. 
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Interviewer: read the questions to the volunteers verbatim and allocate the correct answer from the 
selection, unless it is indicated that you read out each answer to the volunteer as well. Boxed type is 
instructions to the interviewer. Type in italics is to be read to the volunteer. 
Please try to answer these questions accurately as the answers to them are very important to the 
outcome of the study. Remember that the information you give us is confidential and will only be used 
for the purposes of this study.  
Section 1: Gel accountability 
 
1 
 
Interviewer, write the number of applicators dispensed at the last visit according to the last CRF     
 
2 
 
Interviewer, write the number of used applicators returned today     
 
3 
 
Interviewer, write the number of unused applicators returned today     
 
4 
 
How many applicators have you used since your last visit?     
 
Interviewer: check the number of applicators returned (questions 2 & 3) corresponds with the 
number dispensed (question 1). Specify below in question 5 if there is any discrepancy. If no 
discrepancy, go to section 2. 
 
5 What happened to the missing applicators? 
 
Left them behind    Lost them   
 
Gave them to someone else    Threw them away   
 
Other    Specify_________________________ 
 
Section 2: Family planning 
 
6 
 
Are you currently using any method of family planning? 
 
Yes 
 
No 
 
  
 
→ Q. 6a 
 
→ Q. 6b 
6a If yes, which of the following methods are you using?  
Natural/rhythm    → Q. 2 
  
Pills 
 
Diaphragm 
 
Injectable Depo-Provera 
 
IUCD 
 
Condom (male or female) 
 
Traditional oral 
 
Other (specify)
  
  
  
  
  
  
  
Foam/jelly/spermicide [exclude if 
using spermicides regularly 
 
Injectable Nur-Isterate 
 
Injectable other 
 
Norplant implant 
 
Traditional vaginal 
 
Traditional other 
__________________________
__________________________ 
 
 
 
 
 
 
 
→ Q. 2 
 
→ Q. 2 
 
→ Q. 2 
 
→ Q. 2 
 
→ Q. 2 
 
→ Q. 2 
 
6b 
 
If no, why are you not using any method of family planning? 
 
Breastfeeding    
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Wanting to become pregnant 
 
Menopause 
 
Other 
  
  
  
 
Not sexually active 
 
Sterilised (participant or partner) 
 
Specify____________________ 
 
 
 
 
 
7 
 
How many days ago was the first day of your last menstrual period? [List number, 99 if more than 3 
months or 00 if menstruating now]      
 
7a 
 
Was this period when you expected it to be?  
 
Yes 
 
 Refer for clinical assessment No
  
  
 
 
 
 
Section 3: Sexual activity and condom use 
 
Interviewer: please spend some time ensuring that the volunteer understands what is termed by a 
sex act: one sex act is “penetrative vaginal sex that may or may not end with ejaculation”.  
“I am now going to ask you about your sexual activity, gel and condom use. Please answer 
accurately as the responses are very important to the study results.” 
 
8 
 
1 (includes today)    2    → Q. 9 
 
 
How many days ago did you last 
have sex? 
 
 
 
 
3
5
7
 
 
  
  
  
 
 
4 
 
6 
 
 
 
1-4 weeks 
 
 
 
  
 
→ Q. 9 
 
→ Q. 9 
 
→ Q. 9 
 
→ Q. 15 
   
More than 4 weeks    → Q. 22 
 
9 
 
How many times have you had sex in the last week? 
 
[list number of times or 77 if unsure]    
 
10 
 
How many different people have you had sex with in the last week? 
 
[list number or 77 if unsure]    
Ensure that the volunteer understands what we mean by each category of partner. 1) Long-term 
stable relationships include some/most of the following characteristics: official marriage, traditional 
marriage, bride price paid, man known to and accepted by woman’s family, have children together, 
live together, long-term relationship, man provides regular financial/material support, may be 
cohabiting or non-cohabiting. 2) One-off sexual encounter includes one of the following 
characteristics: occasional sex at party or while away from home, very few sex acts with no 
commitments involved, sex in direct exchange for money or other payment. 3) other types of partner 
are those who are not part of a long-term stable relationship, but someone the woman has seen more 
than once, any other kind of partner who doesn’t fit into the first 2 categories. 
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10a 
 
How many of these partners were: 
   
Long-term stable relationships    
   
One off sexual encounters 
 
Other types of partner
   
   
 
Interviewer: check that the total of the answers given in question 10a is the same as the answer 
given in question 10 and rectify if necessary. 
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Interviewer: only fill this table in with participants who HAVE had sex in the last 1 week. 
 “Now I am going to ask you some more detailed questions about your condom and gel use each time you had sex in the last week.” 
Interviewer: each question (row) refers to a particular sex act. Go through all columns for the individual sex act before moving on to the next row. Write the number 
corresponding to the answer code for each column in the box in each cell. Remind the participant about the definition of a ‘sex act’ and allow enough time for the 
participant to carefully consider each answer. 
11. Partner Condom Gel Gel timing Vaginal Cleaning Washing timing Partner informed 
Sex acts in the 
last week 
What type of partner was 
this act with? 
Did you use a 
condom during this 
sex act? 
Did you use gel 
before this sex 
act? 
If you used the gel 
how long before sex 
did you insert it?  
Did you clean inside your 
vagina after sex? (This 
includes using a dry cloth) 
If you cleaned, how 
long after sex was 
this? 
If you used the gel, did 
you tell your partner 
about it? 
Codes 1=long-term stable 
relationship  
2=one off sexual 
encounter,  
3=other type of partner 
8=don’t remember 
1=yes 
2=no 
8=don’t remember 
1=yes 
2=no 
8=don’t remember 
1=less than 1 hour 
2= 1 to 3 hours 
3= more than 3 hours 
8=don’t remember 
9=didn’t use it 
1=yes 
2=no 
8=don’t remember 
1=less than 1 hour 
2= 1 to 2 hours 
3= more than 2 hours 
8=don’t remember 
9=didn’t clean 
1=yes 
2=no 
8=don’t remember 
9=didn’t use it 
1 last sex act               
2 sex act before 
that               
3 sex act before 
that               
4 etc.               
5               
6               
7               
8               
9               
10               
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Interviewer: read each of the responses to questions 12 to 14 to the participant so she can choose 
the one that most accurately reflects her answer 
 
12 How confident are you that the responses you gave to the detailed questions about sex, condom and gel 
use in the last week are accurate? 
  
Very confident they are accurate 
 
Quite confident but I may have mistaken some details 
 
Not very confident about the accuracy of my answers 
 
Not at all confident about the accuracy of my answers 
  
  
  
  
 
13 How often was a condom used when you had sex in the last 4 weeks?    
  
Always 
 
Sometimes
  
  
 
Most of the time 
 
Never 
  
  
 
14 How often was the gel used before you had sex in the last  week?  
Always    → Q. 20 
  
Most of the time 
 
  
 
 
Sometimes 
 
Never 
  
  
 
→ Q. 19 
 
→ Q. 19 
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Interviewer: only fill this table in with participants who have NOT have sex in the last 1 week but who HAVE had sex in the last 4 weeks. 
“Now I am going to ask you some more detailed questions about each sex act in the last 4 weeks. Please answer the questions for each time you had sex.” 
Interviewer: each question (row) refers to a particular sex act. Go through all columns for the individual sex act before moving on to the next row. Write the number 
corresponding to the answer code for each column in the box in each cell. Remind the participant about the definition of a ‘sex act’ and allow enough time for the 
participant to carefully consider each answer. 
15. Partner Condom Gel Gel timing Vaginal Cleaning Washing timing Partner informed 
Sex acts in the 
last week 
What type of partner 
was this act with? 
Did you use a 
condom during this 
sex act? 
Did you use gel 
before this sex act? 
If you used the gel, 
how long before sex 
did you insert it?  
Did you clean inside your 
vagina after sex? (This 
includes using a dry cloth) 
If you washed, how 
long after sex was 
this? 
If you used the gel, 
did you tell your 
partner about it? 
Codes 1=long-term stable 
relationship  
2=one off sexual 
encounter,  
3=other type of partner 
8=don’t remember 
1=yes 
2=no 
8=don’t remember 
1=yes 
2=no 
8=don’t remember 
1=less than 1 hour 
2= 1 to 3 hours 
3= more than 3 hours 
8=don’t remember 
9=didn’t use it 
1=yes 
2=no 
8=don’t remember 
1=less than 1 hour 
2= 1 to 2 hours 
3= more than 2 hours 
8=don’t remember 
9=didn’t clean 
1=yes 
2=no 
8=don’t remember 
9=didn’t use it 
1 last sex act               
2 sex act before 
that               
3 sex act before 
that               
4 etc.               
5               
6               
7               
8               
9               
10               
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Interviewer: read each of the responses to questions 16 to 19 to the participant so she can choose 
the one that most accurately reflects her answer 
 
16 How confident are you that the responses you gave to the detailed questions about sex, condom and gel use 
in the last 4 weeks are accurate? 
  
Very certain they are accurate 
 
Quite certain but I may have mistaken some details 
 
Not very certain about the accuracy of my answers 
 
Not at all certain about the accuracy of my answers 
 
 
 
  
 
17 How often was a condom used when you had sex in the last 4 weeks?   
  
Always 
 
Sometimes
  
  
 
Most of the time 
 
Never 
 
  
 
18 How often was the gel used before you had sex in the last 4 weeks?  
Always    → Q. 20 
  
Most of the time 
 
  
 
 
Sometimes 
 
Never 
 
  
 
 
 
19 If you didn’t use the gel every time you had sex, why not? (tick each that applies)    
  
Found it physically difficult to apply the gel 
 
Didn’t have the gel with me 
 
Didn’t like the gel 
 
No opportunity to insert the gel 
 
Other
  
  
  
  
  
 
Partner opposition 
 
Ran out of gel 
 
Didn’t like the applicator 
 
 
Specify:____________________
___________________________ 
 
 
 
 
 
 
20 
 
In the last 4 weeks, did you ever insert the gel and then not proceed to having sex?  Yes    
   No    → Q. 21 
 
20a 
 
How many times did this happen? 
 
List number of times or 77 if not sure     
 
21 
 
In the last 4 weeks have you had sex whilst you were menstruating?  Yes     
   
No    → Q. 22 
 
21a 
 
If yes, did you use the gel at this (these) times? 
 
Always    
  
Most of the time 
 
 
 
 
Sometimes 
 
Never 
 
  
 
 
Section 4: Other products and practices 
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“Some women insert products into their vaginas for a variety of reasons, such as cleaning inside the 
vagina, or drying or lubricating the vagina before sex. The next questions are about this”. 
 
 
22 
 
Yes     
 
 
In the last week have you inserted anything other than the study gel (excluding 
water/fingers/tampon) into your vagina?  
No    → Q. 23 
 
22a 
 
Why did you insert this other 
thing? 
 
To clean the vagina 
 
To dry the vagina 
 
Other
 
 
  
 
To lubricate the vagina 
 
Specify_____________
___________________
___________________ 
   
22b If yes, how many times did you do this?    
  
More than once per day 
 
Less than once per day but more than once in the 
week
 
  
 
Once per day 
 
Once in the week 
 
Don’t remember 
 
 
  
 
 
22c 
 
What time of day did you normally do this? 
 
Morning    Afternoon    
  
Evening      
22d When in relation to sex did you normally 
do this? 
 
After sex    Before sex    
     Some other time    
 
22e 
 
What did you insert? 
     MULTIPLE ANSWERS 
Disinfectant    Creams    
  
Vaseline 
 
Herbs 
 
 
 
Other
 
 
 
  
 
Dry cloth 
 
Wet cloth 
 
Lemon 
 
Specify: 
 
 
  
 
 
Interviewer: spend some time making sure the participant understands what anal sex is: “penetrative 
anal sex that may or may not end with ejaculation”. 
 
 
23 
“Some women have anal sex. The next question refers to this practice”. 
 
Have you had anal sex in the last 4 weeks? 
 
Yes    
   
No    → Q. 24 
 
23a 
 
Did you use a condom? 
 
Always    Most of the time    
  
Sometimes    Never    
 
Section 5: Acceptability 
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“I now want to ask you some questions about how easy the gel is to use and if you had any problems 
using it.” 
Interviewer: explain that question 24 is about ease of inserting the gel into the vagina and question 
25 is about things in the immediate environment that facilitate or hinder gel use such as having 
children/partner around, lighting, access to water etc. 
 
 
24 
 
Was the insertion of the gel easy or 
difficult? 
 
Very easy    Easy    → Q. 25 
   
Difficult    Very difficult     
24a If difficult/very difficult, why? 
____________________________________________________________________________________
____________________________________________________________________________________ 
 
25 
 
Was it convenient or inconvenient to use the gel?  
  
Convenient    → Q. 26 
    
Inconvenient    
25a If inconvenient, why? 
____________________________________________________________________________________
____________________________________________________________________________________ 
 
26 
 
Did you feel the gel during sexual intercourse? 
  
Yes    
    
No    → Q. 27 
26a If yes, what did you feel? 
____________________________________________________________________________________
____________________________________________________________________________________ 
 
26b 
 
Did you like this feeling? 
  
Yes    
    
No    
    
Neither    
 
27 
 
Did using the gel interfere with sex in any way? 
  
Yes    
    
No    → Q. 28 
27a If yes, how did it interfere? 
____________________________________________________________________________________
____________________________________________________________________________________ 
 
28 
 
Did the gel affect your enjoyment of sex? 
  
Yes    
    
No    → Q. 29 
 
28a 
 
If yes, how? 
 
More enjoyable    Less enjoyable    
 
29 
 
Have you noticed any change in vaginal discharge since using the gel? 
 
Yes    
   
No    
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30 
 
Have you noticed any change in vaginal irritation or itching since using the gel? 
 
Yes    
    
No    → Q. 31 
 
30a 
 
If yes, how? 
 
More irritation    More itching    
   
Less irritation    Less itching    
 
31 
 
Did you have any other problems using the gel? 
  
Yes    
   
No    → Q. 32 
31a If yes, what were they? 
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________ 
32 What do you like most about the gel? 
____________________________________________________________________________________
____________________________________________________________________________________ 
33 What do you like least about the gel? 
____________________________________________________________________________________
____________________________________________________________________________________ 
 
34 
 
Did you tell any of your partners you were using the gel? 
  
Yes 
 
No 
 
 
 
 
 
→ Q. 35 
34a If you told any of them, why? 
____________________________________________________________________________________
____________________________________________________________________________________ 
 
35 
 
Did any of those you did not tell find out? 
  
Yes    
    
No    → Q. 37 
35a If yes, what was their response? 
____________________________________________________________________________________
____________________________________________________________________________________ 
 
36 
 
How did your partner(s) respond to the gel? 
  
(All) liked it    
  
Some liked it and some didn’t like it    (All) didn’t like it    
  
Partner(s) didn’t notice/mention the gel      
 
37 
 
Would you recommend the gel to others? 
  
Yes    → Q. 37a 
  
Don’t know    No    → Q. 37b 
37a If yes, why? 
____________________________________________________________________________________
____________________________________________________________________________________ 
37b If no, why not? 
____________________________________________________________________________________
____________________________________________________________________________________ 
38 Would you be willing to use a gel before sex for a longer period of about a year?  
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Yes    
    
No    
 
39 
 
Have you had any difficulty answering these questions? 
 
Yes    
    
No    → Q. 40 
 
39a 
 
If yes, which ones? 
 
Gel accountability    Family planning    
  
Sexual activity and condom use    Acceptability    
  
Other products & practices      
39b If yes, in what way? 
____________________________________________________________________________________
____________________________________________________________________________________ 
 
40 Interviewer, please tick whether you think the participant has had some difficulty answering any of 
these questions. 
    
Yes    
    
No    
Section 6: Pregnancy test and clinical symptoms 
 
41 
 
Is pregnancy test indicated? 
 
Yes    → Q. 41b 
   
No    → Q. 41a 
 
41a 
 
Why not? 
  
Participant on hormonal contraception    
  
Participant has IUCD fitted    Participant sterilised    
 
41b 
 
Has urine sample been collected?   Yes    → Q. 42 
    No    → Q. 41c 
 
41c Why not? _______________________________________________________________________________ 
 
42 
 
Have you experienced any bleeding or 
spotting that was not your period in the last 
week? 
 
Refer for clinical assessment Yes 
 
No 
   
  
 
43 
 
Have you experienced any genital sores or ulcers in 
the last week? 
 
 Refer for clinical assessment Yes 
 
No 
  
  
 
44 
 
Have you experienced any genital 
discomfort in the last week? 
 
 Refer for clinical assessment Yes 
 
No 
  
  
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45 
 
Have you had any other symptoms in the last 4 weeks 
that you thought were serious enough to make you 
want to see a doctor or nurse? 
 
 Refer for clinical assessment Yes 
 
No 
  
  
Section 7: Contacts 
 
46 
 
Do you give your consent for a member of the study team to contact your partner to 
ask him some questions about the gel? 
 
Yes 
 
No 
  
  
 
 
 
→ Q. 47 
 
46a 
 
Did you tell this partner about your participation in the study? 
 
Yes 
 
No 
  
  
 
47 
 
Do you give your consent to be contacted at 
a later date about future microbicide trials? 
 
Yes 
 
No 
  
  
 
Interviewer code     
 
 
Comments 
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________ 
 
                   MDP 301 PILOT 01 – CRF-CD COMPARISON TABLE – CFRCD   27-08-04 
Site name: Africa Centre for Health and 
Population Studies 
Trial number:         Initials:     Date of visit:   /  /      
                         DD  /MM / YYYY 
 
Signature: 
 
Print name: Date: 
 
 
CRF QUESTION CRF Answer CD Question CD answer 
2. No. of Applicators used  No. of times gel used in 4 weeks  
8. Had Sex in last week or only last 4 weeks 
or more than 4 weeks ago  
 Sex reported in last week or last 4 
weeks  or not in last 4 weeks 
 
9./15 No. of times had sex in last week/4weeks  No. of times had sex in last week/4 
weeks 
 
10. No. of partners in last week  Different types of partners reported  
 
11/15. 
Acts 
Partners Condom Gel Gel timing Vaginal 
Cleaning 
Washing timing Partner informed  
i.         
ii.         
iii.        
 
 
 
13 How often condoms used  No. of condoms  
19 Reason no gel   
 
21 Sex during menstruation last month (21a. gel)   
22 Insert anything in vagina last month (22e. what)   
23 Anal sex last month (24. condom)  Anal Sex   
 
24 Easy or difficult   
25 Convenient/inconvenient   
26 Feel the gel   
27 Interfere    
28  Affect enjoyment (28a. How)   
29 Discharge   
 
 
 
MDP 301 PILOT 01 – COITAL DIARY – CD   27-08-04 
 
Site name: Africa Centre for Health and Population Studies Date Issued:   /  /      
                        DD/MM/YYYY 
Date Returned:   /  /                 DD/MM/YYYY 
Trial number:         Initials:     
 
Signature Print name Date 
WEEK ONE Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Type of a partner 
 
 
                     
 
 
 
 
                    Type of sex 
 
                     
 
 
 
 
                    Condom use 
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WEEK THREE Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
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Type of a partner 
 
 
                     
 
 
 
 
                    Type of sex 
 
                     
 
 
 
 
                    Condom use 
 
                     
 
 
 
 
                    Gel use  
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WEEK FOUR Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
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